Intelligent Virus Defense
Introducing Centinel™ Technology
The first commercially available gene-editing tool to confer viral resistance to CHO cell lines
We are committed to developing leading-edge solutions to advance the biopharma manufacturing industry. With Centinel™ technology, you leverage a powerful combination of tailored biologic solutions and advanced gene-editing technologies to ensure manufacturing processes that are both secure and sustainable.Viral Resistance for the Future
Centinel™ technology goes beyond viral insurance. It’s an integral component of a sophisticated virus mitigation strategy for preventing, detecting and removing viruses.
- Drive organizational value by reducing the risk of viral contamination
- Defend valuable product investment from potential harm
- Deliver advanced virus resistance to biopharmaceutical manufacturers, supporting process efficiency and consumer safety
- Gene-Editing Reagents for Engineering a Viral-Resistant Cell Line
- Cell-Line Engineering Services for Viral Resistance
- Viral Challenge Assays by BioReliance for Confirming Viral Resistance
We are Now One
Merck and Sigma-Aldrich bring together world-class products, services and innovative capabilities to create a global leader in the life science industry.